Evidence map›Paper›PMID 40107700›Full record

ArticleBMJ open2025

Exploring patient engagement in atrial fibrillation with multimorbidity: impact on quality of life, medication adherence and healthcare perceptions-a multicountry cross-sectional study.

Caterina Bosio, Dilara Usta, Donato Leo, Caterina Trevisan, Deirdre Lane, Guendalina Graffigna, AFFIRMO Project Consortium

Abstract readMulticenter Study
In one paragraph

Article in BMJ open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Attitudes toward partner notification ofFrontiers in public health · 2026
    Article
  3. Patient health engagement as a predictor of symptom outcomes in patients receiving chemotherapy.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Caterina BosioEngageMinds HUB - Consumer, Food and Health Engagement Research Center, Universita Cattolica del Sacro Cuore, Cremona, Lombardia, Italy.
Dilara UstaEngageMinds HUB - Consumer, Food and Health Engagement Research Center, Universita Cattolica del Sacro Cuore, Cremona, Lombardia, Italy dilara.cengiz@unicatt.it.ORCID http://orcid.org/0000-0003-1300-0678
Donato LeoDepartment of Cardiovascular and Metabolic Medicine, University of Liverpool, Liverpool, UK.
Caterina TrevisanDepartment of Medicine, Università degli Studi di Padova, Padova, Veneto, Italy.
Deirdre LaneDepartment of Cardiovascular and Metabolic Medicine, University of Liverpool, Liverpool, UK.ORCID http://orcid.org/0000-0002-5604-9378
Guendalina GraffignaEngageMinds HUB - Consumer, Food and Health Engagement Research Center, Universita Cattolica del Sacro Cuore, Cremona, Lombardia, Italy.
AFFIRMO Project Consortium

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo examine patient engagement (PE) levels of atrial fibrillation (AF) patients with multimorbidity, to identify distinct personas based on sociodemographic and clinical characteristics, as well as engagement levels, and to compare PE in disease management with health-related quality of life, medication adherence, and perceptions of care quality.

designA cross-sectional survey.

settingData were collected through an online survey platform between 31 May 2022 and 31 January 2023 from five European countries (Denmark, Italy, Romania, Spain and the UK).

participantsThe study involved 659 AF patients older than 18 years who were diagnosed with one or more concomitant chronic health conditions. PRIMARY AND SECONDARY OUTCOME MEASURES: The survey focused on identifying the needs and quality performance indicators (QPIs) of patients. Emotional engagement was evaluated using the Patient Health Engagement Scale (PHE-s), and cognitive-behavioural engagement was assessed using the Altarum Consumer Engagement Measure (ACE). Engagement scores of each measure were grouped as high or low and compared by age group, sex, level of education and country of recruitment, health-related quality of life, medication adherence and perception of care quality using χ

resultsAmong the 659 AF patients (70.9±10.2 years, 52.8% female), 428 (65%) were categorised as having high emotional PE levels based on PHE-s and were significantly more likely to be <75 years old and male, have a secondary level of education or above, and have <3 comorbidities (p<0.05). Regarding the ACE scores, 369 (56%) were classified as having high cognitive-behavioural PE levels and were more likely to be <65 years old, reside in Northern Europe, have degree-level education or higher, and have <3 comorbidities (p<0.05). Additionally, participants with high emotional PE demonstrated better quality of life, medication adherence and perceptions of quality of care, whereas those with higher levels of cognitive-behavioural PE had better quality of life and perceptions of quality of care.

conclusionsFrom a clinical perspective, the findings highlight the need for a personalised approach sensitive to the expectations and needs of AF patients. The present research suggests that implementing sociodemographic and clinical profiling for AF patients could facilitate the formulation of improved care strategies.

Indexed as

Atrial FibrillationMedication AdherencePatient ParticipationQuality of LifeAgedAged, 80 and overCross-Sectional StudiesEuropeFemaleHumansMaleMiddle AgedMultimorbidityQuality of Health CareSurveys and QuestionnairesMedication AdherenceMultimorbidityPatient-Centered CarePatient Reported Outcome MeasuresQuality of Life

Identifiers

PMID40107700
PMCPMC11927486

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.